What We Do

The Thrombolysis in Myocardial Infarction (TIMI) Study Group is an Academic Research Organization (ARO) dedicated to advancing the knowledge and care of patients suffering from cardiovascular disease.  The TIMI Study Group is part of Brigham and Women’s Hospital and affiliated with Harvard Medical School and is headquartered in Boston, Massachusetts

The TIMI Study Group provides robust expertise in the key aspects of a clinical trial including academic leadership, global trial management, biostatistics, clinical event adjudication, safety desk, medical hotline, and core laboratories. We have dedicated teams for each of these core functions, with close collaboration between physicians and operational personnel on all key aspects.

Academic Trial Leadership

Global Trial Management


Clinical Events Committee

Safety Desk

Medical Hotline

Core Labs

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close